Product news

Share this article:
Mylan has received final FDA approval for its fluoxetine capsules—10 mg and 20 mg—a generic form of Lilly's antidepressant, Sarafem Pulvules Capsules. Sarafem Pulvules Capsules brought in roughly $19.2 million for the 12 months ending Sept. 30, according to IMS Health. 
 
Two Johnson & Johnson subsidiaries (Janssen and ALZA) were found liable in the death of a Cicero, IL, woman, who died while using a Duragesic patch. A Chicago court awarded Janice DiCosolo's family with $16.5 million. DiCosolo's family argued that the defendants were aware of the patch's defect, which caused fentanyl to leak in large enough amounts to be fatal. 

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions